Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 21 studies | 22% ± 6% | |
natural killer cell | 7 studies | 17% ± 1% | |
conventional dendritic cell | 7 studies | 25% ± 10% | |
monocyte | 6 studies | 24% ± 6% | |
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 17% ± 2% | |
epithelial cell | 6 studies | 28% ± 11% | |
classical monocyte | 5 studies | 23% ± 6% | |
myeloid cell | 5 studies | 30% ± 5% | |
endothelial cell | 5 studies | 24% ± 5% | |
fibroblast | 4 studies | 23% ± 7% | |
non-classical monocyte | 3 studies | 22% ± 3% | |
dendritic cell | 3 studies | 31% ± 5% | |
endothelial cell of vascular tree | 3 studies | 18% ± 1% | |
alveolar macrophage | 3 studies | 20% ± 4% | |
oligodendrocyte | 3 studies | 23% ± 5% | |
mononuclear phagocyte | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4273.00 | 258 / 258 | 100% | 29.84 | 230 / 230 |
esophagus | 100% | 2936.23 | 1445 / 1445 | 100% | 23.88 | 183 / 183 |
liver | 100% | 2193.20 | 226 / 226 | 100% | 32.11 | 406 / 406 |
ovary | 100% | 3157.87 | 180 / 180 | 100% | 23.02 | 430 / 430 |
skin | 100% | 3794.28 | 1809 / 1809 | 100% | 36.52 | 472 / 472 |
thymus | 100% | 3374.96 | 653 / 653 | 100% | 42.41 | 605 / 605 |
uterus | 100% | 3268.05 | 170 / 170 | 100% | 45.23 | 459 / 459 |
lung | 100% | 4555.24 | 578 / 578 | 100% | 36.77 | 1154 / 1155 |
brain | 100% | 2097.19 | 2634 / 2642 | 100% | 37.76 | 705 / 705 |
pancreas | 100% | 1552.87 | 327 / 328 | 100% | 49.32 | 178 / 178 |
kidney | 100% | 2874.42 | 89 / 89 | 100% | 45.41 | 898 / 901 |
stomach | 100% | 2368.28 | 359 / 359 | 100% | 33.55 | 285 / 286 |
intestine | 100% | 3404.44 | 966 / 966 | 100% | 38.29 | 525 / 527 |
bladder | 100% | 3369.24 | 21 / 21 | 100% | 43.06 | 502 / 504 |
prostate | 100% | 3352.78 | 245 / 245 | 99% | 32.63 | 499 / 502 |
breast | 100% | 3711.13 | 459 / 459 | 99% | 40.34 | 1105 / 1118 |
adipose | 100% | 4174.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 23.92 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 56.76 | 29 / 29 |
spleen | 100% | 5290.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 24.30 | 1 / 1 |
muscle | 100% | 2234.61 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2621.83 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 2120.37 | 859 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 3287.07 | 923 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002639 | Biological process | positive regulation of immunoglobulin production |
GO_0050921 | Biological process | positive regulation of chemotaxis |
GO_0006886 | Biological process | intracellular protein transport |
GO_0017157 | Biological process | regulation of exocytosis |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0043311 | Biological process | positive regulation of eosinophil degranulation |
GO_0034394 | Biological process | protein localization to cell surface |
GO_0060291 | Biological process | long-term synaptic potentiation |
GO_2000010 | Biological process | positive regulation of protein localization to cell surface |
GO_0043085 | Biological process | positive regulation of catalytic activity |
GO_0035493 | Biological process | SNARE complex assembly |
GO_0035774 | Biological process | positive regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0006887 | Biological process | exocytosis |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_1903575 | Biological process | cornified envelope assembly |
GO_0048278 | Biological process | vesicle docking |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0048284 | Biological process | organelle fusion |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0006906 | Biological process | vesicle fusion |
GO_1902041 | Biological process | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005615 | Cellular component | extracellular space |
GO_0043219 | Cellular component | lateral loop |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0000322 | Cellular component | storage vacuole |
GO_0012505 | Cellular component | endomembrane system |
GO_0016020 | Cellular component | membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0036477 | Cellular component | somatodendritic compartment |
GO_0005773 | Cellular component | vacuole |
GO_0070062 | Cellular component | extracellular exosome |
GO_0098794 | Cellular component | postsynapse |
GO_0042581 | Cellular component | specific granule |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0032589 | Cellular component | neuron projection membrane |
GO_0005768 | Cellular component | endosome |
GO_0030027 | Cellular component | lamellipodium |
GO_0031201 | Cellular component | SNARE complex |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0035749 | Cellular component | myelin sheath adaxonal region |
GO_0016230 | Molecular function | sphingomyelin phosphodiesterase activator activity |
GO_0000149 | Molecular function | SNARE binding |
GO_0005484 | Molecular function | SNAP receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | STX4 |
Protein name | Syntaxin 4 Syntaxin-4 (Renal carcinoma antigen NY-REN-31) |
Synonyms | STX4A |
Description | FUNCTION: Plasma membrane t-SNARE that mediates docking of transport vesicles (By similarity). Necessary for the translocation of SLC2A4 from intracellular vesicles to the plasma membrane (By similarity). In neurons, recruited at neurite tips to membrane domains rich in the phospholipid 1-oleoyl-2-palmitoyl-PC (OPPC) which promotes neurite tip surface expression of the dopamine transporter SLC6A3/DAT by facilitating fusion of SLC6A3-containing transport vesicles with the plasma membrane (By similarity). Together with STXB3 and VAMP2, may also play a role in docking/fusion of intracellular GLUT4-containing vesicles with the cell surface in adipocytes and in docking of synaptic vesicles at presynaptic active zones (By similarity). . |
Accessions | ENST00000613541.1 H3BMK2 ENST00000460668.5 ENST00000496977.5 C9JFM5 ENST00000457779.6 A0A087WWW0 Q12846 ENST00000313843.8 [Q12846-1] ENST00000394998.5 [Q12846-2] |